Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
Abstract Therapies targeting somatic bystander genetic events represent a new avenue for cancer treatment. We recently identified a subset of colorectal cancer (CRC) patients who are heterozygous for a wild-type and a low activity allele (NAT2*6) but lack the wild-type allele in their tumors due to...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/0075eeada5c6431e9aaae378bc12e7b8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|